nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulindac—CYP1A2—Carmustine—brain cancer	0.119	0.364	CbGbCtD
Sulindac—PTGS2—Etoposide—brain cancer	0.0934	0.286	CbGbCtD
Sulindac—PTGS1—Etoposide—brain cancer	0.0789	0.242	CbGbCtD
Sulindac—CYP1A2—Etoposide—brain cancer	0.0352	0.108	CbGbCtD
Sulindac—MAPK3—endothelium—brain cancer	0.00796	0.0594	CbGeAlD
Sulindac—MAPK3—blood vessel—brain cancer	0.00734	0.0547	CbGeAlD
Sulindac—PTGDR2—cerebellum—brain cancer	0.00514	0.0383	CbGeAlD
Sulindac—AKR1B1—telencephalon—brain cancer	0.00492	0.0366	CbGeAlD
Sulindac—PTGDR2—brain—brain cancer	0.00417	0.0311	CbGeAlD
Sulindac—AKR1B1—gonad—brain cancer	0.0041	0.0306	CbGeAlD
Sulindac—AKR1B1—pituitary gland—brain cancer	0.004	0.0298	CbGeAlD
Sulindac—PPARD—telencephalon—brain cancer	0.00387	0.0288	CbGeAlD
Sulindac—AKR1B1—medulla oblongata—brain cancer	0.00386	0.0288	CbGeAlD
Sulindac—MAPK3—telencephalon—brain cancer	0.00356	0.0266	CbGeAlD
Sulindac—AKR1B1—midbrain—brain cancer	0.00353	0.0263	CbGeAlD
Sulindac—AKR1B1—spinal cord—brain cancer	0.00344	0.0257	CbGeAlD
Sulindac—AKR1B1—endocrine gland—brain cancer	0.0031	0.0231	CbGeAlD
Sulindac—AKR1B1—head—brain cancer	0.00306	0.0228	CbGeAlD
Sulindac—MAPK3—gonad—brain cancer	0.00297	0.0222	CbGeAlD
Sulindac—MAPK3—pituitary gland—brain cancer	0.0029	0.0216	CbGeAlD
Sulindac—MAPK3—medulla oblongata—brain cancer	0.0028	0.0209	CbGeAlD
Sulindac—AKR1B1—central nervous system—brain cancer	0.00279	0.0208	CbGeAlD
Sulindac—PPARD—midbrain—brain cancer	0.00278	0.0207	CbGeAlD
Sulindac—AKR1B1—cerebellum—brain cancer	0.00273	0.0204	CbGeAlD
Sulindac—MAPK3—midbrain—brain cancer	0.00256	0.0191	CbGeAlD
Sulindac—PTGS1—ganglion—brain cancer	0.00251	0.0187	CbGeAlD
Sulindac—MAPK3—spinal cord—brain cancer	0.0025	0.0186	CbGeAlD
Sulindac—PPARD—endocrine gland—brain cancer	0.00244	0.0182	CbGeAlD
Sulindac—PPARD—head—brain cancer	0.00241	0.0179	CbGeAlD
Sulindac—MAPK3—endocrine gland—brain cancer	0.00225	0.0168	CbGeAlD
Sulindac—MAPK3—head—brain cancer	0.00222	0.0165	CbGeAlD
Sulindac—AKR1B1—brain—brain cancer	0.00222	0.0165	CbGeAlD
Sulindac—PPARD—central nervous system—brain cancer	0.0022	0.0164	CbGeAlD
Sulindac—PTGS1—endothelium—brain cancer	0.00216	0.0161	CbGeAlD
Sulindac—PPARD—cerebellum—brain cancer	0.00215	0.016	CbGeAlD
Sulindac—PTGS2—endothelium—brain cancer	0.00207	0.0154	CbGeAlD
Sulindac—MAPK3—central nervous system—brain cancer	0.00203	0.0151	CbGeAlD
Sulindac—PTGS1—blood vessel—brain cancer	0.002	0.0149	CbGeAlD
Sulindac—MAPK3—cerebellum—brain cancer	0.00198	0.0148	CbGeAlD
Sulindac—PTGS2—blood vessel—brain cancer	0.00191	0.0142	CbGeAlD
Sulindac—PPARD—brain—brain cancer	0.00174	0.013	CbGeAlD
Sulindac—MAPK3—brain—brain cancer	0.00161	0.012	CbGeAlD
Sulindac—Anorexia—Lomustine—brain cancer	0.00138	0.00538	CcSEcCtD
Sulindac—Haematuria—Procarbazine—brain cancer	0.00138	0.00536	CcSEcCtD
Sulindac—Epistaxis—Procarbazine—brain cancer	0.00136	0.0053	CcSEcCtD
Sulindac—Body temperature increased—Carboplatin—brain cancer	0.00131	0.0051	CcSEcCtD
Sulindac—Gastroenteritis—Temozolomide—brain cancer	0.00128	0.00497	CcSEcCtD
Sulindac—Vascular purpura—Temozolomide—brain cancer	0.00127	0.00493	CcSEcCtD
Sulindac—Decreased appetite—Lomustine—brain cancer	0.00126	0.00491	CcSEcCtD
Sulindac—Hepatic failure—Temozolomide—brain cancer	0.00126	0.00491	CcSEcCtD
Sulindac—SLC22A6—brain—brain cancer	0.00123	0.00917	CbGeAlD
Sulindac—Pancreatitis—Hydroxyurea—brain cancer	0.00123	0.00478	CcSEcCtD
Sulindac—Flushing—Procarbazine—brain cancer	0.0012	0.00468	CcSEcCtD
Sulindac—Dermatitis exfoliative—Temozolomide—brain cancer	0.0012	0.00467	CcSEcCtD
Sulindac—Pancytopenia—Hydroxyurea—brain cancer	0.00119	0.00463	CcSEcCtD
Sulindac—Purpura—Temozolomide—brain cancer	0.00118	0.00457	CcSEcCtD
Sulindac—Gastrointestinal haemorrhage—Carmustine—brain cancer	0.00117	0.00456	CcSEcCtD
Sulindac—Neutropenia—Hydroxyurea—brain cancer	0.00117	0.00456	CcSEcCtD
Sulindac—Dysuria—Hydroxyurea—brain cancer	0.00117	0.00456	CcSEcCtD
Sulindac—Chills—Procarbazine—brain cancer	0.00116	0.00453	CcSEcCtD
Sulindac—Arrhythmia—Procarbazine—brain cancer	0.00116	0.00451	CcSEcCtD
Sulindac—Body temperature increased—Lomustine—brain cancer	0.00115	0.00446	CcSEcCtD
Sulindac—Alopecia—Procarbazine—brain cancer	0.00115	0.00446	CcSEcCtD
Sulindac—Tension—Procarbazine—brain cancer	0.00111	0.00431	CcSEcCtD
Sulindac—Nervousness—Procarbazine—brain cancer	0.0011	0.00427	CcSEcCtD
Sulindac—Neuropathy peripheral—Hydroxyurea—brain cancer	0.0011	0.00426	CcSEcCtD
Sulindac—Stomatitis—Hydroxyurea—brain cancer	0.00109	0.00424	CcSEcCtD
Sulindac—Anaemia—Procarbazine—brain cancer	0.00104	0.00406	CcSEcCtD
Sulindac—Muscular weakness—Carmustine—brain cancer	0.00103	0.00402	CcSEcCtD
Sulindac—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.00102	0.00397	CcSEcCtD
Sulindac—Syncope—Procarbazine—brain cancer	0.00101	0.00394	CcSEcCtD
Sulindac—Leukopenia—Procarbazine—brain cancer	0.00101	0.00393	CcSEcCtD
Sulindac—Cardiac failure congestive—Etoposide—brain cancer	0.001	0.00389	CcSEcCtD
Sulindac—Muscular weakness—Temozolomide—brain cancer	0.000999	0.00389	CcSEcCtD
Sulindac—Loss of consciousness—Procarbazine—brain cancer	0.000992	0.00386	CcSEcCtD
Sulindac—Convulsion—Procarbazine—brain cancer	0.000978	0.00381	CcSEcCtD
Sulindac—Hypertension—Procarbazine—brain cancer	0.000975	0.00379	CcSEcCtD
Sulindac—PTGS1—telencephalon—brain cancer	0.000968	0.00722	CbGeAlD
Sulindac—Pancytopenia—Carmustine—brain cancer	0.000963	0.00374	CcSEcCtD
Sulindac—Myalgia—Procarbazine—brain cancer	0.000961	0.00374	CcSEcCtD
Sulindac—Arthralgia—Procarbazine—brain cancer	0.000961	0.00374	CcSEcCtD
Sulindac—Sweating increased—Temozolomide—brain cancer	0.000954	0.00371	CcSEcCtD
Sulindac—Neutropenia—Carmustine—brain cancer	0.000948	0.00369	CcSEcCtD
Sulindac—Pancytopenia—Temozolomide—brain cancer	0.00093	0.00362	CcSEcCtD
Sulindac—PTGS2—telencephalon—brain cancer	0.000926	0.0069	CbGeAlD
Sulindac—Vomiting—Lomustine—brain cancer	0.000923	0.00359	CcSEcCtD
Sulindac—Oedema—Procarbazine—brain cancer	0.000921	0.00358	CcSEcCtD
Sulindac—Neutropenia—Temozolomide—brain cancer	0.000916	0.00356	CcSEcCtD
Sulindac—Dysuria—Temozolomide—brain cancer	0.000916	0.00356	CcSEcCtD
Sulindac—Hyperglycaemia—Carmustine—brain cancer	0.000914	0.00356	CcSEcCtD
Sulindac—Pneumonia—Carmustine—brain cancer	0.000909	0.00354	CcSEcCtD
Sulindac—Shock—Procarbazine—brain cancer	0.000906	0.00353	CcSEcCtD
Sulindac—Thrombocytopenia—Procarbazine—brain cancer	0.000902	0.00351	CcSEcCtD
Sulindac—Depression—Carmustine—brain cancer	0.000901	0.00351	CcSEcCtD
Sulindac—Chills—Hydroxyurea—brain cancer	0.0009	0.0035	CcSEcCtD
Sulindac—Tachycardia—Procarbazine—brain cancer	0.000899	0.0035	CcSEcCtD
Sulindac—Photosensitivity reaction—Temozolomide—brain cancer	0.000894	0.00348	CcSEcCtD
Sulindac—Hyperhidrosis—Procarbazine—brain cancer	0.000891	0.00347	CcSEcCtD
Sulindac—Renal failure—Carmustine—brain cancer	0.000888	0.00346	CcSEcCtD
Sulindac—Alopecia—Hydroxyurea—brain cancer	0.000887	0.00345	CcSEcCtD
Sulindac—Neuropathy peripheral—Carmustine—brain cancer	0.000886	0.00345	CcSEcCtD
Sulindac—Hyperglycaemia—Temozolomide—brain cancer	0.000884	0.00344	CcSEcCtD
Sulindac—Stomatitis—Carmustine—brain cancer	0.000881	0.00343	CcSEcCtD
Sulindac—Pneumonia—Temozolomide—brain cancer	0.000878	0.00342	CcSEcCtD
Sulindac—Anorexia—Procarbazine—brain cancer	0.000878	0.00342	CcSEcCtD
Sulindac—Depression—Temozolomide—brain cancer	0.000871	0.00339	CcSEcCtD
Sulindac—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000866	0.00337	CcSEcCtD
Sulindac—Nausea—Lomustine—brain cancer	0.000862	0.00335	CcSEcCtD
Sulindac—Hypotension—Procarbazine—brain cancer	0.000861	0.00335	CcSEcCtD
Sulindac—Neuropathy peripheral—Temozolomide—brain cancer	0.000856	0.00333	CcSEcCtD
Sulindac—Stomatitis—Temozolomide—brain cancer	0.000851	0.00331	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000839	0.00327	CcSEcCtD
Sulindac—Insomnia—Procarbazine—brain cancer	0.000833	0.00324	CcSEcCtD
Sulindac—Paraesthesia—Procarbazine—brain cancer	0.000827	0.00322	CcSEcCtD
Sulindac—Somnolence—Procarbazine—brain cancer	0.000819	0.00319	CcSEcCtD
Sulindac—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000817	0.00318	CcSEcCtD
Sulindac—Ill-defined disorder—Hydroxyurea—brain cancer	0.000811	0.00315	CcSEcCtD
Sulindac—Anaemia—Hydroxyurea—brain cancer	0.000807	0.00314	CcSEcCtD
Sulindac—Decreased appetite—Procarbazine—brain cancer	0.000801	0.00312	CcSEcCtD
Sulindac—Fatigue—Procarbazine—brain cancer	0.000794	0.00309	CcSEcCtD
Sulindac—PTGS1—pituitary gland—brain cancer	0.000788	0.00588	CbGeAlD
Sulindac—Malaise—Hydroxyurea—brain cancer	0.000788	0.00307	CcSEcCtD
Sulindac—Constipation—Procarbazine—brain cancer	0.000788	0.00307	CcSEcCtD
Sulindac—Hepatitis—Temozolomide—brain cancer	0.000784	0.00305	CcSEcCtD
Sulindac—Leukopenia—Hydroxyurea—brain cancer	0.000782	0.00304	CcSEcCtD
Sulindac—Visual impairment—Carmustine—brain cancer	0.000782	0.00304	CcSEcCtD
Sulindac—Bronchospasm—Etoposide—brain cancer	0.000771	0.003	CcSEcCtD
Sulindac—ALB—brain—brain cancer	0.000767	0.00572	CbGeAlD
Sulindac—Sweating increased—Etoposide—brain cancer	0.000763	0.00297	CcSEcCtD
Sulindac—Feeling abnormal—Procarbazine—brain cancer	0.000759	0.00295	CcSEcCtD
Sulindac—Convulsion—Hydroxyurea—brain cancer	0.000757	0.00294	CcSEcCtD
Sulindac—Visual impairment—Temozolomide—brain cancer	0.000755	0.00294	CcSEcCtD
Sulindac—PTGS2—pituitary gland—brain cancer	0.000754	0.00562	CbGeAlD
Sulindac—Gastrointestinal pain—Procarbazine—brain cancer	0.000753	0.00293	CcSEcCtD
Sulindac—Flushing—Carmustine—brain cancer	0.000753	0.00293	CcSEcCtD
Sulindac—Pancytopenia—Etoposide—brain cancer	0.000744	0.0029	CcSEcCtD
Sulindac—Erythema multiforme—Temozolomide—brain cancer	0.000741	0.00288	CcSEcCtD
Sulindac—Discomfort—Hydroxyurea—brain cancer	0.000735	0.00286	CcSEcCtD
Sulindac—Neutropenia—Etoposide—brain cancer	0.000733	0.00285	CcSEcCtD
Sulindac—Urticaria—Procarbazine—brain cancer	0.000732	0.00285	CcSEcCtD
Sulindac—Tinnitus—Temozolomide—brain cancer	0.000731	0.00284	CcSEcCtD
Sulindac—Body temperature increased—Procarbazine—brain cancer	0.000728	0.00283	CcSEcCtD
Sulindac—Flushing—Temozolomide—brain cancer	0.000728	0.00283	CcSEcCtD
Sulindac—PTGS2—medulla oblongata—brain cancer	0.000727	0.00542	CbGeAlD
Sulindac—Arrhythmia—Carmustine—brain cancer	0.000725	0.00282	CcSEcCtD
Sulindac—Alopecia—Carmustine—brain cancer	0.000717	0.00279	CcSEcCtD
Sulindac—Oedema—Hydroxyurea—brain cancer	0.000713	0.00277	CcSEcCtD
Sulindac—CYP1A2—endocrine gland—brain cancer	0.000705	0.00525	CbGeAlD
Sulindac—Chills—Temozolomide—brain cancer	0.000703	0.00274	CcSEcCtD
Sulindac—Pneumonia—Etoposide—brain cancer	0.000703	0.00273	CcSEcCtD
Sulindac—Thrombocytopenia—Hydroxyurea—brain cancer	0.000698	0.00272	CcSEcCtD
Sulindac—CYP1A1—endocrine gland—brain cancer	0.000695	0.00518	CbGeAlD
Sulindac—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000693	0.0027	CcSEcCtD
Sulindac—Alopecia—Temozolomide—brain cancer	0.000693	0.0027	CcSEcCtD
Sulindac—Renal failure—Etoposide—brain cancer	0.000687	0.00267	CcSEcCtD
Sulindac—CYP1A1—head—brain cancer	0.000686	0.00512	CbGeAlD
Sulindac—Neuropathy peripheral—Etoposide—brain cancer	0.000685	0.00267	CcSEcCtD
Sulindac—Jaundice—Etoposide—brain cancer	0.000681	0.00265	CcSEcCtD
Sulindac—Stomatitis—Etoposide—brain cancer	0.000681	0.00265	CcSEcCtD
Sulindac—Anorexia—Hydroxyurea—brain cancer	0.00068	0.00264	CcSEcCtD
Sulindac—Hypersensitivity—Procarbazine—brain cancer	0.000679	0.00264	CcSEcCtD
Sulindac—PTGS1—spinal cord—brain cancer	0.000678	0.00506	CbGeAlD
Sulindac—Dysgeusia—Temozolomide—brain cancer	0.000668	0.0026	CcSEcCtD
Sulindac—Vision blurred—Carmustine—brain cancer	0.000666	0.00259	CcSEcCtD
Sulindac—PTGS2—midbrain—brain cancer	0.000665	0.00495	CbGeAlD
Sulindac—Asthenia—Procarbazine—brain cancer	0.000661	0.00257	CcSEcCtD
Sulindac—Anaemia—Carmustine—brain cancer	0.000653	0.00254	CcSEcCtD
Sulindac—Agranulocytosis—Etoposide—brain cancer	0.000652	0.00254	CcSEcCtD
Sulindac—Pruritus—Procarbazine—brain cancer	0.000652	0.00254	CcSEcCtD
Sulindac—PTGS2—spinal cord—brain cancer	0.000648	0.00483	CbGeAlD
Sulindac—Vision blurred—Temozolomide—brain cancer	0.000643	0.0025	CcSEcCtD
Sulindac—Dyspnoea—Hydroxyurea—brain cancer	0.000636	0.00247	CcSEcCtD
Sulindac—Somnolence—Hydroxyurea—brain cancer	0.000634	0.00247	CcSEcCtD
Sulindac—Ill-defined disorder—Temozolomide—brain cancer	0.000633	0.00246	CcSEcCtD
Sulindac—Leukopenia—Carmustine—brain cancer	0.000632	0.00246	CcSEcCtD
Sulindac—Anaemia—Temozolomide—brain cancer	0.000631	0.00245	CcSEcCtD
Sulindac—Diarrhoea—Procarbazine—brain cancer	0.00063	0.00245	CcSEcCtD
Sulindac—Dyspepsia—Hydroxyurea—brain cancer	0.000628	0.00244	CcSEcCtD
Sulindac—CYP1A1—central nervous system—brain cancer	0.000626	0.00467	CbGeAlD
Sulindac—Angioedema—Temozolomide—brain cancer	0.000624	0.00243	CcSEcCtD
Sulindac—Decreased appetite—Hydroxyurea—brain cancer	0.00062	0.00241	CcSEcCtD
Sulindac—Malaise—Temozolomide—brain cancer	0.000615	0.00239	CcSEcCtD
Sulindac—Fatigue—Hydroxyurea—brain cancer	0.000615	0.00239	CcSEcCtD
Sulindac—Vertigo—Temozolomide—brain cancer	0.000613	0.00239	CcSEcCtD
Sulindac—Convulsion—Carmustine—brain cancer	0.000612	0.00238	CcSEcCtD
Sulindac—Leukopenia—Temozolomide—brain cancer	0.000611	0.00238	CcSEcCtD
Sulindac—PTGS1—endocrine gland—brain cancer	0.000611	0.00455	CbGeAlD
Sulindac—Hypertension—Carmustine—brain cancer	0.00061	0.00237	CcSEcCtD
Sulindac—Constipation—Hydroxyurea—brain cancer	0.00061	0.00237	CcSEcCtD
Sulindac—Dizziness—Procarbazine—brain cancer	0.000609	0.00237	CcSEcCtD
Sulindac—Palpitations—Temozolomide—brain cancer	0.000603	0.00235	CcSEcCtD
Sulindac—PTGS1—head—brain cancer	0.000603	0.00449	CbGeAlD
Sulindac—Chest pain—Carmustine—brain cancer	0.000601	0.00234	CcSEcCtD
Sulindac—Myalgia—Carmustine—brain cancer	0.000601	0.00234	CcSEcCtD
Sulindac—Erythema multiforme—Etoposide—brain cancer	0.000593	0.00231	CcSEcCtD
Sulindac—Convulsion—Temozolomide—brain cancer	0.000591	0.0023	CcSEcCtD
Sulindac—Hypertension—Temozolomide—brain cancer	0.000589	0.00229	CcSEcCtD
Sulindac—Feeling abnormal—Hydroxyurea—brain cancer	0.000588	0.00229	CcSEcCtD
Sulindac—Vomiting—Procarbazine—brain cancer	0.000586	0.00228	CcSEcCtD
Sulindac—PTGS2—endocrine gland—brain cancer	0.000584	0.00435	CbGeAlD
Sulindac—Flushing—Etoposide—brain cancer	0.000582	0.00227	CcSEcCtD
Sulindac—Arthralgia—Temozolomide—brain cancer	0.000581	0.00226	CcSEcCtD
Sulindac—Myalgia—Temozolomide—brain cancer	0.000581	0.00226	CcSEcCtD
Sulindac—Rash—Procarbazine—brain cancer	0.000581	0.00226	CcSEcCtD
Sulindac—Dermatitis—Procarbazine—brain cancer	0.00058	0.00226	CcSEcCtD
Sulindac—Headache—Procarbazine—brain cancer	0.000577	0.00225	CcSEcCtD
Sulindac—Oedema—Carmustine—brain cancer	0.000576	0.00224	CcSEcCtD
Sulindac—PTGS2—head—brain cancer	0.000576	0.0043	CbGeAlD
Sulindac—Discomfort—Temozolomide—brain cancer	0.000574	0.00223	CcSEcCtD
Sulindac—Thrombocytopenia—Carmustine—brain cancer	0.000564	0.0022	CcSEcCtD
Sulindac—Body temperature increased—Hydroxyurea—brain cancer	0.000564	0.00219	CcSEcCtD
Sulindac—Chills—Etoposide—brain cancer	0.000563	0.00219	CcSEcCtD
Sulindac—Tachycardia—Carmustine—brain cancer	0.000563	0.00219	CcSEcCtD
Sulindac—Anaphylactic shock—Temozolomide—brain cancer	0.000557	0.00217	CcSEcCtD
Sulindac—Oedema—Temozolomide—brain cancer	0.000557	0.00217	CcSEcCtD
Sulindac—Alopecia—Etoposide—brain cancer	0.000554	0.00216	CcSEcCtD
Sulindac—PTGS1—central nervous system—brain cancer	0.00055	0.0041	CbGeAlD
Sulindac—Anorexia—Carmustine—brain cancer	0.000549	0.00214	CcSEcCtD
Sulindac—Nausea—Procarbazine—brain cancer	0.000547	0.00213	CcSEcCtD
Sulindac—Thrombocytopenia—Temozolomide—brain cancer	0.000545	0.00212	CcSEcCtD
Sulindac—Hypotension—Carmustine—brain cancer	0.000539	0.0021	CcSEcCtD
Sulindac—Hyperhidrosis—Temozolomide—brain cancer	0.000538	0.00209	CcSEcCtD
Sulindac—Dysgeusia—Etoposide—brain cancer	0.000535	0.00208	CcSEcCtD
Sulindac—Anorexia—Temozolomide—brain cancer	0.000531	0.00207	CcSEcCtD
Sulindac—PTGS2—central nervous system—brain cancer	0.000526	0.00392	CbGeAlD
Sulindac—Hypersensitivity—Hydroxyurea—brain cancer	0.000525	0.00204	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Carmustine—brain cancer	0.000525	0.00204	CcSEcCtD
Sulindac—Insomnia—Carmustine—brain cancer	0.000521	0.00203	CcSEcCtD
Sulindac—Paraesthesia—Carmustine—brain cancer	0.000518	0.00201	CcSEcCtD
Sulindac—PTGS2—cerebellum—brain cancer	0.000514	0.00383	CbGeAlD
Sulindac—Dyspnoea—Carmustine—brain cancer	0.000514	0.002	CcSEcCtD
Sulindac—Somnolence—Carmustine—brain cancer	0.000512	0.00199	CcSEcCtD
Sulindac—Asthenia—Hydroxyurea—brain cancer	0.000512	0.00199	CcSEcCtD
Sulindac—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000507	0.00197	CcSEcCtD
Sulindac—Ill-defined disorder—Etoposide—brain cancer	0.000507	0.00197	CcSEcCtD
Sulindac—Anaemia—Etoposide—brain cancer	0.000505	0.00196	CcSEcCtD
Sulindac—Insomnia—Temozolomide—brain cancer	0.000504	0.00196	CcSEcCtD
Sulindac—Decreased appetite—Carmustine—brain cancer	0.000501	0.00195	CcSEcCtD
Sulindac—Paraesthesia—Temozolomide—brain cancer	0.0005	0.00195	CcSEcCtD
Sulindac—CYP1A1—brain—brain cancer	0.000497	0.00371	CbGeAlD
Sulindac—Dyspnoea—Temozolomide—brain cancer	0.000497	0.00193	CcSEcCtD
Sulindac—Somnolence—Temozolomide—brain cancer	0.000495	0.00193	CcSEcCtD
Sulindac—Constipation—Carmustine—brain cancer	0.000493	0.00192	CcSEcCtD
Sulindac—Malaise—Etoposide—brain cancer	0.000492	0.00192	CcSEcCtD
Sulindac—Vertigo—Etoposide—brain cancer	0.000491	0.00191	CcSEcCtD
Sulindac—Dyspepsia—Temozolomide—brain cancer	0.00049	0.00191	CcSEcCtD
Sulindac—Leukopenia—Etoposide—brain cancer	0.000489	0.0019	CcSEcCtD
Sulindac—Diarrhoea—Hydroxyurea—brain cancer	0.000488	0.0019	CcSEcCtD
Sulindac—Decreased appetite—Temozolomide—brain cancer	0.000484	0.00188	CcSEcCtD
Sulindac—Fatigue—Temozolomide—brain cancer	0.00048	0.00187	CcSEcCtD
Sulindac—Loss of consciousness—Etoposide—brain cancer	0.00048	0.00187	CcSEcCtD
Sulindac—Constipation—Temozolomide—brain cancer	0.000476	0.00185	CcSEcCtD
Sulindac—Feeling abnormal—Carmustine—brain cancer	0.000475	0.00185	CcSEcCtD
Sulindac—Convulsion—Etoposide—brain cancer	0.000473	0.00184	CcSEcCtD
Sulindac—Hypertension—Etoposide—brain cancer	0.000471	0.00183	CcSEcCtD
Sulindac—Dizziness—Hydroxyurea—brain cancer	0.000471	0.00183	CcSEcCtD
Sulindac—Gastrointestinal pain—Carmustine—brain cancer	0.000471	0.00183	CcSEcCtD
Sulindac—Chest pain—Etoposide—brain cancer	0.000465	0.00181	CcSEcCtD
Sulindac—Discomfort—Etoposide—brain cancer	0.000459	0.00179	CcSEcCtD
Sulindac—Feeling abnormal—Temozolomide—brain cancer	0.000459	0.00179	CcSEcCtD
Sulindac—Body temperature increased—Carmustine—brain cancer	0.000456	0.00177	CcSEcCtD
Sulindac—Gastrointestinal pain—Temozolomide—brain cancer	0.000455	0.00177	CcSEcCtD
Sulindac—Vomiting—Hydroxyurea—brain cancer	0.000453	0.00176	CcSEcCtD
Sulindac—Rash—Hydroxyurea—brain cancer	0.00045	0.00175	CcSEcCtD
Sulindac—Dermatitis—Hydroxyurea—brain cancer	0.000449	0.00175	CcSEcCtD
Sulindac—Headache—Hydroxyurea—brain cancer	0.000447	0.00174	CcSEcCtD
Sulindac—Anaphylactic shock—Etoposide—brain cancer	0.000446	0.00173	CcSEcCtD
Sulindac—Urticaria—Temozolomide—brain cancer	0.000442	0.00172	CcSEcCtD
Sulindac—Body temperature increased—Temozolomide—brain cancer	0.00044	0.00171	CcSEcCtD
Sulindac—PTGS1—brain—brain cancer	0.000437	0.00326	CbGeAlD
Sulindac—Thrombocytopenia—Etoposide—brain cancer	0.000436	0.0017	CcSEcCtD
Sulindac—Tachycardia—Etoposide—brain cancer	0.000435	0.00169	CcSEcCtD
Sulindac—Hyperhidrosis—Etoposide—brain cancer	0.000431	0.00168	CcSEcCtD
Sulindac—Anorexia—Etoposide—brain cancer	0.000425	0.00165	CcSEcCtD
Sulindac—Hypersensitivity—Carmustine—brain cancer	0.000425	0.00165	CcSEcCtD
Sulindac—Nausea—Hydroxyurea—brain cancer	0.000423	0.00165	CcSEcCtD
Sulindac—PTGS2—brain—brain cancer	0.000418	0.00311	CbGeAlD
Sulindac—Hypotension—Etoposide—brain cancer	0.000416	0.00162	CcSEcCtD
Sulindac—Asthenia—Carmustine—brain cancer	0.000414	0.00161	CcSEcCtD
Sulindac—Hypersensitivity—Temozolomide—brain cancer	0.00041	0.0016	CcSEcCtD
Sulindac—Paraesthesia—Etoposide—brain cancer	0.0004	0.00156	CcSEcCtD
Sulindac—Asthenia—Temozolomide—brain cancer	0.0004	0.00155	CcSEcCtD
Sulindac—Dyspnoea—Etoposide—brain cancer	0.000397	0.00155	CcSEcCtD
Sulindac—Somnolence—Etoposide—brain cancer	0.000396	0.00154	CcSEcCtD
Sulindac—Diarrhoea—Carmustine—brain cancer	0.000394	0.00153	CcSEcCtD
Sulindac—Pruritus—Temozolomide—brain cancer	0.000394	0.00153	CcSEcCtD
Sulindac—Decreased appetite—Etoposide—brain cancer	0.000387	0.00151	CcSEcCtD
Sulindac—Fatigue—Etoposide—brain cancer	0.000384	0.0015	CcSEcCtD
Sulindac—Dizziness—Carmustine—brain cancer	0.000381	0.00148	CcSEcCtD
Sulindac—Constipation—Etoposide—brain cancer	0.000381	0.00148	CcSEcCtD
Sulindac—Diarrhoea—Temozolomide—brain cancer	0.000381	0.00148	CcSEcCtD
Sulindac—Dizziness—Temozolomide—brain cancer	0.000368	0.00143	CcSEcCtD
Sulindac—Feeling abnormal—Etoposide—brain cancer	0.000367	0.00143	CcSEcCtD
Sulindac—Vomiting—Carmustine—brain cancer	0.000366	0.00143	CcSEcCtD
Sulindac—Gastrointestinal pain—Etoposide—brain cancer	0.000364	0.00142	CcSEcCtD
Sulindac—Rash—Carmustine—brain cancer	0.000363	0.00141	CcSEcCtD
Sulindac—Dermatitis—Carmustine—brain cancer	0.000363	0.00141	CcSEcCtD
Sulindac—Headache—Carmustine—brain cancer	0.000361	0.0014	CcSEcCtD
Sulindac—Vomiting—Temozolomide—brain cancer	0.000354	0.00138	CcSEcCtD
Sulindac—Urticaria—Etoposide—brain cancer	0.000354	0.00138	CcSEcCtD
Sulindac—Body temperature increased—Etoposide—brain cancer	0.000352	0.00137	CcSEcCtD
Sulindac—Rash—Temozolomide—brain cancer	0.000351	0.00137	CcSEcCtD
Sulindac—Dermatitis—Temozolomide—brain cancer	0.000351	0.00137	CcSEcCtD
Sulindac—Headache—Temozolomide—brain cancer	0.000349	0.00136	CcSEcCtD
Sulindac—Nausea—Carmustine—brain cancer	0.000342	0.00133	CcSEcCtD
Sulindac—Nausea—Temozolomide—brain cancer	0.000331	0.00129	CcSEcCtD
Sulindac—Hypersensitivity—Etoposide—brain cancer	0.000328	0.00128	CcSEcCtD
Sulindac—Asthenia—Etoposide—brain cancer	0.00032	0.00124	CcSEcCtD
Sulindac—Pruritus—Etoposide—brain cancer	0.000315	0.00123	CcSEcCtD
Sulindac—Diarrhoea—Etoposide—brain cancer	0.000305	0.00119	CcSEcCtD
Sulindac—Dizziness—Etoposide—brain cancer	0.000295	0.00115	CcSEcCtD
Sulindac—Vomiting—Etoposide—brain cancer	0.000283	0.0011	CcSEcCtD
Sulindac—Rash—Etoposide—brain cancer	0.000281	0.00109	CcSEcCtD
Sulindac—Dermatitis—Etoposide—brain cancer	0.000281	0.00109	CcSEcCtD
Sulindac—Headache—Etoposide—brain cancer	0.000279	0.00109	CcSEcCtD
Sulindac—Nausea—Etoposide—brain cancer	0.000265	0.00103	CcSEcCtD
Sulindac—MAPK3—Cell Cycle, Mitotic—CCNE1—brain cancer	0.000109	0.000386	CbGpPWpGaD
Sulindac—MAPK3—Spinal Cord Injury—TP53—brain cancer	0.000108	0.000382	CbGpPWpGaD
Sulindac—MAPK3—Oxidative Stress Induced Senescence—TP53—brain cancer	0.000107	0.000379	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PTCH2—brain cancer	0.000107	0.000378	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—SIRT1—brain cancer	0.000107	0.000378	CbGpPWpGaD
Sulindac—MAPK3—Regulation of Actin Cytoskeleton—EGFR—brain cancer	0.000107	0.000378	CbGpPWpGaD
Sulindac—MAPK3—Downstream signaling of activated FGFR—EGFR—brain cancer	0.000107	0.000378	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—VAV1—brain cancer	0.000106	0.000374	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB4—EGFR—brain cancer	0.000105	0.000372	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—IL2—brain cancer	0.000105	0.000371	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HES5—brain cancer	0.000104	0.000367	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—HES1—brain cancer	0.000103	0.000364	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000103	0.000363	CbGpPWpGaD
Sulindac—PTGS2—C-MYB transcription factor network—MYC—brain cancer	0.000103	0.000363	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—STAT3—brain cancer	0.000102	0.000362	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000102	0.000362	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—CDKN2A—brain cancer	0.000102	0.00036	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—IL2—brain cancer	0.000102	0.00036	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—BRCA2—brain cancer	0.000101	0.000357	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—STRADA—brain cancer	0.0001	0.000356	CbGpPWpGaD
Sulindac—MAPK3—Downstream signal transduction—EGFR—brain cancer	0.0001	0.000355	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—STAT3—brain cancer	0.0001	0.000354	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—IL2—brain cancer	9.99e-05	0.000354	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR—EGFR—brain cancer	9.97e-05	0.000353	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IRS2—brain cancer	9.96e-05	0.000353	CbGpPWpGaD
Sulindac—MAPK3—Disease—IDH1—brain cancer	9.95e-05	0.000352	CbGpPWpGaD
Sulindac—MAPK3—Signaling by ERBB2—EGFR—brain cancer	9.92e-05	0.000351	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—MYC—brain cancer	9.9e-05	0.000351	CbGpPWpGaD
Sulindac—MAPK3—DAP12 signaling—EGFR—brain cancer	9.87e-05	0.00035	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	9.87e-05	0.00035	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—STAT3—brain cancer	9.82e-05	0.000348	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—RELA—brain cancer	9.8e-05	0.000347	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—CCNE1—brain cancer	9.75e-05	0.000345	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—CCND1—brain cancer	9.74e-05	0.000345	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	9.71e-05	0.000344	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—EGFR—brain cancer	9.69e-05	0.000343	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—PCNA—brain cancer	9.66e-05	0.000342	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	9.66e-05	0.000342	CbGpPWpGaD
Sulindac—MAPK3—Disease—HEY1—brain cancer	9.43e-05	0.000334	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	9.39e-05	0.000333	CbGpPWpGaD
Sulindac—ALB—Platelet degranulation—VEGFA—brain cancer	9.38e-05	0.000332	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—RELA—brain cancer	9.35e-05	0.000331	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—SHH—brain cancer	9.32e-05	0.00033	CbGpPWpGaD
Sulindac—MAPK3—DAP12 interactions—EGFR—brain cancer	9.29e-05	0.000329	CbGpPWpGaD
Sulindac—MAPK3—Fc epsilon receptor (FCERI) signaling—EGFR—brain cancer	9.29e-05	0.000329	CbGpPWpGaD
Sulindac—MAPK3—Signaling by FGFR in disease—EGFR—brain cancer	9.29e-05	0.000329	CbGpPWpGaD
Sulindac—MAPK3—Disease—DLL1—brain cancer	9.25e-05	0.000327	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR—EGFR—brain cancer	9.21e-05	0.000326	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	9.19e-05	0.000325	CbGpPWpGaD
Sulindac—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	9.19e-05	0.000325	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—RELA—brain cancer	9.19e-05	0.000325	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—ERBB2—brain cancer	9.13e-05	0.000323	CbGpPWpGaD
Sulindac—MAPK3—Signaling by EGFR in Cancer—EGFR—brain cancer	9.13e-05	0.000323	CbGpPWpGaD
Sulindac—MAPK3—Signaling by PDGF—EGFR—brain cancer	9.09e-05	0.000322	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	9.05e-05	0.000321	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—IDH1—brain cancer	9e-05	0.000319	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—TRPC6—brain cancer	8.99e-05	0.000318	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	8.94e-05	0.000316	CbGpPWpGaD
Sulindac—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—brain cancer	8.93e-05	0.000316	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—PTCH1—brain cancer	8.83e-05	0.000313	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—SMO—brain cancer	8.83e-05	0.000313	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—APC—brain cancer	8.8e-05	0.000312	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—PIK3CG—brain cancer	8.8e-05	0.000312	CbGpPWpGaD
Sulindac—PTGS2—Disease—HES5—brain cancer	8.79e-05	0.000311	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	8.74e-05	0.00031	CbGpPWpGaD
Sulindac—PPARD—Generic Transcription Pathway—MYC—brain cancer	8.69e-05	0.000308	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—PDGFRA—brain cancer	8.65e-05	0.000306	CbGpPWpGaD
Sulindac—MAPK3—Platelet activation, signaling and aggregation—VEGFA—brain cancer	8.64e-05	0.000306	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—PCNA—brain cancer	8.64e-05	0.000306	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.61e-05	0.000305	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—CYP2C9—brain cancer	8.53e-05	0.000302	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—IL2—brain cancer	8.42e-05	0.000298	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ABR—brain cancer	8.39e-05	0.000297	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—CDK4—brain cancer	8.35e-05	0.000296	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—ERBB2—brain cancer	8.26e-05	0.000293	CbGpPWpGaD
Sulindac—ALB—Folate Metabolism—TP53—brain cancer	8.26e-05	0.000293	CbGpPWpGaD
Sulindac—MAPK3—NGF signalling via TRKA from the plasma membrane—EGFR—brain cancer	8.23e-05	0.000291	CbGpPWpGaD
Sulindac—MAPK3—MAPK Signaling Pathway—TP53—brain cancer	8.13e-05	0.000288	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—GLI2—brain cancer	8.1e-05	0.000287	CbGpPWpGaD
Sulindac—MAPK3—Immune System—SKP2—brain cancer	8.07e-05	0.000286	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—CDK4—brain cancer	8.07e-05	0.000286	CbGpPWpGaD
Sulindac—PTGDR2—Signaling by GPCR—EGFR—brain cancer	8.02e-05	0.000284	CbGpPWpGaD
Sulindac—MAPK3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	7.95e-05	0.000282	CbGpPWpGaD
Sulindac—MAPK3—Disease—ENO2—brain cancer	7.86e-05	0.000278	CbGpPWpGaD
Sulindac—MAPK3—Disease—SHH—brain cancer	7.86e-05	0.000278	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—MYC—brain cancer	7.81e-05	0.000277	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—EGFR—brain cancer	7.64e-05	0.000271	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—GLI1—brain cancer	7.61e-05	0.00027	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—IRS2—brain cancer	7.59e-05	0.000269	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—DNMT1—brain cancer	7.55e-05	0.000267	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TRPC6—brain cancer	7.53e-05	0.000267	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	7.5e-05	0.000266	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—VEGFA—brain cancer	7.5e-05	0.000266	CbGpPWpGaD
Sulindac—MAPK3—Cellular Senescence—TP53—brain cancer	7.5e-05	0.000265	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—CDK4—brain cancer	7.47e-05	0.000264	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—PIK3CG—brain cancer	7.45e-05	0.000264	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—STAT3—brain cancer	7.42e-05	0.000263	CbGpPWpGaD
Sulindac—MAPK3—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	7.34e-05	0.00026	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—BSG—brain cancer	7.26e-05	0.000257	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SUFU—brain cancer	7.22e-05	0.000256	CbGpPWpGaD
Sulindac—MAPK3—Cytokine Signaling in Immune system—STAT3—brain cancer	7.08e-05	0.000251	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—GFAP—brain cancer	6.96e-05	0.000247	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—STAT3—brain cancer	6.96e-05	0.000247	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—PIK3CG—brain cancer	6.95e-05	0.000246	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—RELA—brain cancer	6.88e-05	0.000244	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—ERBB2—brain cancer	6.83e-05	0.000242	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—ESR2—brain cancer	6.78e-05	0.00024	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—CYP2C9—brain cancer	6.77e-05	0.00024	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—VAV1—brain cancer	6.73e-05	0.000238	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	6.63e-05	0.000235	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HEY1—brain cancer	6.6e-05	0.000234	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	6.56e-05	0.000232	CbGpPWpGaD
Sulindac—ALB—Transmembrane transport of small molecules—TRPC6—brain cancer	6.52e-05	0.000231	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—DLL1—brain cancer	6.47e-05	0.000229	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—NOTCH2—brain cancer	6.42e-05	0.000227	CbGpPWpGaD
Sulindac—PTGS2—Spinal Cord Injury—TP53—brain cancer	6.42e-05	0.000227	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—CDKN2A—brain cancer	6.38e-05	0.000226	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—VEGFA—brain cancer	6.36e-05	0.000225	CbGpPWpGaD
Sulindac—MAPK3—Signaling by NGF—EGFR—brain cancer	6.33e-05	0.000224	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.29e-05	0.000223	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—IDH1—brain cancer	6.24e-05	0.000221	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—IL2—brain cancer	6.19e-05	0.000219	CbGpPWpGaD
Sulindac—MAPK3—Immune System—VAV1—brain cancer	6.15e-05	0.000218	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CCND1—brain cancer	6.04e-05	0.000214	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—CYP2C9—brain cancer	6.01e-05	0.000213	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—CTNNB1—brain cancer	5.98e-05	0.000212	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—RELA—brain cancer	5.93e-05	0.00021	CbGpPWpGaD
Sulindac—PPARD—Metabolism—PIK3CG—brain cancer	5.92e-05	0.000209	CbGpPWpGaD
Sulindac—PTGS2—Disease—IDH1—brain cancer	5.91e-05	0.000209	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—ERBB2—brain cancer	5.9e-05	0.000209	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	5.78e-05	0.000205	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—BSG—brain cancer	5.76e-05	0.000204	CbGpPWpGaD
Sulindac—MAPK3—Axon guidance—EGFR—brain cancer	5.73e-05	0.000203	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—CDKN2A—brain cancer	5.71e-05	0.000202	CbGpPWpGaD
Sulindac—MAPK3—Disease—VAV1—brain cancer	5.68e-05	0.000201	CbGpPWpGaD
Sulindac—MAPK3—Cellular responses to stress—TP53—brain cancer	5.67e-05	0.000201	CbGpPWpGaD
Sulindac—ALB—Hemostasis—VAV1—brain cancer	5.64e-05	0.0002	CbGpPWpGaD
Sulindac—PTGS2—Disease—HEY1—brain cancer	5.61e-05	0.000199	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SHH—brain cancer	5.51e-05	0.000195	CbGpPWpGaD
Sulindac—PTGS2—Disease—DLL1—brain cancer	5.5e-05	0.000195	CbGpPWpGaD
Sulindac—ALB—Metabolism—CYP2C9—brain cancer	5.48e-05	0.000194	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—SIRT1—brain cancer	5.46e-05	0.000193	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—CCND1—brain cancer	5.39e-05	0.000191	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	5.31e-05	0.000188	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TRPC6—brain cancer	5.31e-05	0.000188	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—VEGFA—brain cancer	5.26e-05	0.000186	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—IL2—brain cancer	5.24e-05	0.000186	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—RELA—brain cancer	5.24e-05	0.000186	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SMO—brain cancer	5.22e-05	0.000185	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PTCH1—brain cancer	5.22e-05	0.000185	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—STAT3—brain cancer	5.21e-05	0.000185	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—ERBB2—brain cancer	5.21e-05	0.000184	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	5.2e-05	0.000184	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—CTNNB1—brain cancer	5.16e-05	0.000183	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—BSG—brain cancer	5.11e-05	0.000181	CbGpPWpGaD
Sulindac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	5.08e-05	0.00018	CbGpPWpGaD
Sulindac—MAPK3—Immune System—PDGFRA—brain cancer	5.04e-05	0.000178	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—IDH1—brain cancer	4.95e-05	0.000175	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—ENO2—brain cancer	4.93e-05	0.000175	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—IL2—brain cancer	4.89e-05	0.000173	CbGpPWpGaD
Sulindac—MAPK3—Disease—HES1—brain cancer	4.89e-05	0.000173	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—MYC—brain cancer	4.84e-05	0.000171	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—CCND1—brain cancer	4.82e-05	0.000171	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—EGFR—brain cancer	4.74e-05	0.000168	CbGpPWpGaD
Sulindac—PTGS2—Disease—ENO2—brain cancer	4.68e-05	0.000166	CbGpPWpGaD
Sulindac—PTGS2—Disease—SHH—brain cancer	4.68e-05	0.000166	CbGpPWpGaD
Sulindac—ALB—Metabolism—BSG—brain cancer	4.66e-05	0.000165	CbGpPWpGaD
Sulindac—MAPK3—Disease—PDGFRA—brain cancer	4.65e-05	0.000165	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—CTNNB1—brain cancer	4.56e-05	0.000161	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—VEGFA—brain cancer	4.54e-05	0.000161	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—STAT3—brain cancer	4.5e-05	0.000159	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—VEGFA—brain cancer	4.46e-05	0.000158	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IRS2—brain cancer	4.42e-05	0.000157	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—IDH1—brain cancer	4.4e-05	0.000156	CbGpPWpGaD
Sulindac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	4.36e-05	0.000155	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle, Mitotic—MYC—brain cancer	4.33e-05	0.000153	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—PIK3CG—brain cancer	4.28e-05	0.000151	CbGpPWpGaD
Sulindac—PPARD—Gene Expression—MYC—brain cancer	4.19e-05	0.000148	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—NOTCH2—brain cancer	4.17e-05	0.000148	CbGpPWpGaD
Sulindac—ALB—Platelet activation, signaling and aggregation—VEGFA—brain cancer	4.16e-05	0.000147	CbGpPWpGaD
Sulindac—MAPK3—Developmental Biology—EGFR—brain cancer	4.09e-05	0.000145	CbGpPWpGaD
Sulindac—MAPK3—Disease—IRS2—brain cancer	4.08e-05	0.000145	CbGpPWpGaD
Sulindac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.03e-05	0.000143	CbGpPWpGaD
Sulindac—ALB—Metabolism—IDH1—brain cancer	4.01e-05	0.000142	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—VAV1—brain cancer	3.98e-05	0.000141	CbGpPWpGaD
Sulindac—PTGDR2—Signaling Pathways—TP53—brain cancer	3.98e-05	0.000141	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—ENO2—brain cancer	3.92e-05	0.000139	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—MYC—brain cancer	3.87e-05	0.000137	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—CYP2C9—brain cancer	3.83e-05	0.000136	CbGpPWpGaD
Sulindac—MAPK3—Innate Immune System—EGFR—brain cancer	3.61e-05	0.000128	CbGpPWpGaD
Sulindac—MAPK3—Disease—APC—brain cancer	3.61e-05	0.000128	CbGpPWpGaD
Sulindac—ALB—Hemostasis—PIK3CG—brain cancer	3.58e-05	0.000127	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.58e-05	0.000127	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—ENO2—brain cancer	3.48e-05	0.000123	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—HES1—brain cancer	3.42e-05	0.000121	CbGpPWpGaD
Sulindac—PTGS2—Disease—VAV1—brain cancer	3.38e-05	0.00012	CbGpPWpGaD
Sulindac—MAPK3—Hemostasis—TP53—brain cancer	3.37e-05	0.000119	CbGpPWpGaD
Sulindac—ALB—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.26e-05	0.000116	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—BSG—brain cancer	3.26e-05	0.000115	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PDGFRA—brain cancer	3.26e-05	0.000115	CbGpPWpGaD
Sulindac—MAPK3—Cell Cycle—TP53—brain cancer	3.18e-05	0.000113	CbGpPWpGaD
Sulindac—ALB—Metabolism—ENO2—brain cancer	3.17e-05	0.000112	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—SPP1—brain cancer	3.16e-05	0.000112	CbGpPWpGaD
Sulindac—MAPK3—Immune System—RELA—brain cancer	3.05e-05	0.000108	CbGpPWpGaD
Sulindac—MAPK3—Immune System—ERBB2—brain cancer	3.03e-05	0.000107	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—IL2—brain cancer	3.01e-05	0.000107	CbGpPWpGaD
Sulindac—PTGS2—Disease—HES1—brain cancer	2.91e-05	0.000103	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IRS2—brain cancer	2.86e-05	0.000101	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—IDH1—brain cancer	2.8e-05	9.93e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—ERBB2—brain cancer	2.8e-05	9.92e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—PDGFRA—brain cancer	2.77e-05	9.8e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—IL2—brain cancer	2.75e-05	9.73e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—CTNNB1—brain cancer	2.65e-05	9.4e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—PIK3CG—brain cancer	2.53e-05	8.94e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—APC—brain cancer	2.53e-05	8.94e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—IL2—brain cancer	2.52e-05	8.93e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—CTNNB1—brain cancer	2.45e-05	8.68e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—IRS2—brain cancer	2.43e-05	8.6e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—STAT3—brain cancer	2.31e-05	8.19e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling by GPCR—EGFR—brain cancer	2.3e-05	8.15e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.28e-05	8.08e-05	CbGpPWpGaD
Sulindac—PTGS1—Metabolism—PIK3CG—brain cancer	2.26e-05	8.01e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—ENO2—brain cancer	2.22e-05	7.85e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—APC—brain cancer	2.14e-05	7.6e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—VEGFA—brain cancer	2.14e-05	7.59e-05	CbGpPWpGaD
Sulindac—MAPK3—Gene Expression—MYC—brain cancer	2.14e-05	7.57e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—STAT3—brain cancer	2.14e-05	7.56e-05	CbGpPWpGaD
Sulindac—MAPK3—Immune System—EGFR—brain cancer	2.1e-05	7.45e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—MYC—brain cancer	1.98e-05	7.03e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—RELA—brain cancer	1.97e-05	6.99e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—ERBB2—brain cancer	1.96e-05	6.94e-05	CbGpPWpGaD
Sulindac—MAPK3—Disease—EGFR—brain cancer	1.94e-05	6.87e-05	CbGpPWpGaD
Sulindac—PTGS2—Metabolism—PIK3CG—brain cancer	1.8e-05	6.36e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—IL2—brain cancer	1.78e-05	6.29e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CCND1—brain cancer	1.73e-05	6.14e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—CTNNB1—brain cancer	1.72e-05	6.08e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—ERBB2—brain cancer	1.67e-05	5.9e-05	CbGpPWpGaD
Sulindac—ALB—Hemostasis—TP53—brain cancer	1.62e-05	5.74e-05	CbGpPWpGaD
Sulindac—CYP1A1—Metabolism—PIK3CG—brain cancer	1.59e-05	5.65e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—VEGFA—brain cancer	1.51e-05	5.35e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—STAT3—brain cancer	1.5e-05	5.3e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—CTNNB1—brain cancer	1.46e-05	5.16e-05	CbGpPWpGaD
Sulindac—ALB—Metabolism—PIK3CG—brain cancer	1.45e-05	5.15e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—MYC—brain cancer	1.39e-05	4.92e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—EGFR—brain cancer	1.36e-05	4.81e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—STAT3—brain cancer	1.27e-05	4.5e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—MYC—brain cancer	1.18e-05	4.18e-05	CbGpPWpGaD
Sulindac—PTGS2—Disease—EGFR—brain cancer	1.15e-05	4.09e-05	CbGpPWpGaD
Sulindac—MAPK3—Signaling Pathways—TP53—brain cancer	1.14e-05	4.04e-05	CbGpPWpGaD
Sulindac—CYP1A2—Metabolism—PIK3CG—brain cancer	1.02e-05	3.6e-05	CbGpPWpGaD
